{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Martin FP"],"funding":["Swiss National Science Foundation"],"pagination":["E1310"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC5000707"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["17(8)"],"pubmed_abstract":["Growth failure and delayed puberty are well known features of children and adolescents with inflammatory bowel disease (IBD), in addition to the chronic course of the disease. Urinary metabonomics was applied in order to better understand metabolic changes between healthy and IBD children. 21 Pediatric patients with IBD (mean age 14.8 years, 8 males) were enrolled from the Pediatric Gastroenterology Outpatient Clinic over two years. Clinical and biological data were collected at baseline, 6, and 12 months. 27 healthy children (mean age 12.9 years, 16 males) were assessed at baseline. Urine samples were collected at each visit and subjected to ¹H Nuclear Magnetic Resonance (NMR) spectroscopy. Using ¹H NMR metabonomics, we determined that urine metabolic profiles of IBD children differ signi"],"journal":["International journal of molecular sciences"],"pubmed_title":["Urinary Metabolic Phenotyping Reveals Differences in the Metabolic Status of Healthy and Inflammatory Bowel Disease (IBD) Children in Relation to Growth and Disease Activity."],"pmcid":["PMC5000707"],"funding_grant_id":["135466","32003B_135466"],"pubmed_authors":["Godin JP","Kussmann M","Martin FP","Cominetti O","Nydegger A","Da Silva L","Ezri J"],"additional_accession":[]},"is_claimable":false,"name":"Urinary Metabolic Phenotyping Reveals Differences in the Metabolic Status of Healthy and Inflammatory Bowel Disease (IBD) Children in Relation to Growth and Disease Activity.","description":"Growth failure and delayed puberty are well known features of children and adolescents with inflammatory bowel disease (IBD), in addition to the chronic course of the disease. Urinary metabonomics was applied in order to better understand metabolic changes between healthy and IBD children. 21 Pediatric patients with IBD (mean age 14.8 years, 8 males) were enrolled from the Pediatric Gastroenterology Outpatient Clinic over two years. Clinical and biological data were collected at baseline, 6, and 12 months. 27 healthy children (mean age 12.9 years, 16 males) were assessed at baseline. Urine samples were collected at each visit and subjected to ¹H Nuclear Magnetic Resonance (NMR) spectroscopy. Using ¹H NMR metabonomics, we determined that urine metabolic profiles of IBD children differ signi","dates":{"release":"2016-01-01T00:00:00Z","publication":"2016 Aug","modification":"2025-04-04T11:56:02.127Z","creation":"2019-03-27T02:22:46Z"},"accession":"S-EPMC5000707","cross_references":{"pubmed":["27529220"],"doi":["10.3390/ijms17081310"]}}